ニュース
Ustekinumab may be more effective than anti-tumor necrosis factor (anti-TNF) therapies in achieving clinical remission among patients with Crohn-like disease of the pouch (CLDP), according to study ...
From 2016 to 2022, 5.3% of all US emergency department visits were related to low back pain, with opioid administration and prescription decreasing during this same time period.
There was an increase in use of neuraxial anesthesia and peripheral nerve block analgesia rather than general anesthesia for hip fracture procedures.
The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health ...
The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
There was an overall decrease in influenza vaccine uptake among US adults from 2020 to 2024, according to a study published online.
Older adults with insomnia are more vulnerable to depressive mood and symptoms in response to inflammatory exposure.
Between the years 2010 and 2019, the percentage of publicly insured children with a mental health or neurodevelopmental diagnosis increased.
Ustekinumab is more efficacious than vedolizumab or anti-TNFs as second- or third-line biologic therapy for perianal Crohn disease.
Osteoporosis treatment was associated with reduced hospitalization and mortality risks following fragility fracture after 80 years of age.
Hydroxychloroquine exposure during the first trimester of pregnancy was associated with a lower risk for preeclampsia among women with SLE.
The US Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they are "obsolete and unnecessary." ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する